Celgene Corp.

Historical 13F Holders

Symbol
CELG
CUSIP
151020104
All holders as of
Q4 2024
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2024 Q4 1 14.6 k $2.47 M
2021 Q2 2 400 $26.0 k
2021 Q1 1 0 $0
2020 Q4 1 0 $0
2020 Q3 1 0 $0
2020 Q2 4 7.08 k $655 k
2020 Q1 4 38.2 k $3.79 M
2019 Q4 6 33.3 k $2.00 M
2019 Q3 1,332 577 M $57.3 B
2019 Q2 1,391 561 M $51.9 B
2019 Q1 1,549 555 M $52.3 B
2018 Q4 1,406 538 M $34.5 B
2018 Q3 1,448 539 M $48.2 B
2018 Q2 1,457 550 M $43.9 B
2018 Q1 1,489 575 M $51.3 B
2017 Q4 1,562 593 M $61.9 B
2017 Q3 1,582 637 M $92.2 B
2017 Q2 1,513 628 M $81.5 B
2017 Q1 1,511 621 M $77.3 B
2016 Q4 1,470 617 M $71.4 B
2016 Q3 1,373 605 M $63.2 B
2016 Q2 1,313 610 M $60.5 B
2016 Q1 1,298 635 M $61.8 B
2015 Q4 1,336 641 M $77.1 B
2015 Q3 1,274 647 M $70.1 B
2015 Q2 1,274 632 M $73.2 B
2015 Q1 1,259 644 M $74.3 B
2014 Q4 1,243 661 M $74.2 B
2014 Q3 1,103 649 M $61.5 B
2014 Q2 1,061 665 M $57.2 B
2014 Q1 1,034 323 M $45.0 B